1. Effects of pro‐inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells. (10th March 2015) Authors: Jean‐Gilles, L.; Braitch, M.; Latif, M. L.; Aram, J.; Fahey, A. J.; Edwards, L. J.; Robins, R. A.; Tanasescu, R.; Tighe, P. J.; Gran, B.; Showe, L. C.; Alexander, S. P.; Chapman, V.; Kendall, D. A.; Constantinescu, C. S. Journal: Acta physiologica Issue: Volume 214:Number 1(2015:May) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Natural and disease‐specific autoantibodies in chronic obstructive pulmonary disease. (April 2015) Authors: Daffa, N. I.; Tighe, P. J.; Corne, J. M.; Fairclough, L. C.; Todd, I. Journal: Clinical and experimental immunology Issue: Volume 180:Number 1(2015:Apr.) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patients with tumour necrosis factor (TNF) receptor‐associated periodic syndrome (TRAPS) are hypersensitive to Toll‐like receptor 9 stimulation. (22nd May 2019) Authors: Negm, O. H.; Singh, S.; Abduljabbar, W.; Hamed, M. R; Radford, P.; McDermott, E. M.; Drewe, E.; Fairclough, L.; Todd, I.; Tighe, P. J. Journal: Clinical and experimental immunology Issue: Volume 197:Number 3(2019) Page Start: 352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗